BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17765421)

  • 1. Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors.
    Yan K; Chen MH; Yang W; Wang YB; Gao W; Hao CY; Xing BC; Huang XF
    Eur J Radiol; 2008 Aug; 67(2):336-347. PubMed ID: 17765421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long term (5 years) outcome of radiofrequency ablation for hepatocellular carcinoma in 256 cases].
    Chen MH; Yan K; Yang W; Gao W; Dai Y; Huo L; Zhang H; Huang XF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):671-2. PubMed ID: 16378128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect and prognostic analysis of radiofrequency ablation in treating advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yan K; Wu W; Yang W
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):735-8. PubMed ID: 22781351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.
    Ng KK; Poon RT; Lo CM; Yuen J; Tso WK; Fan ST
    J Gastrointest Surg; 2008 Jan; 12(1):183-91. PubMed ID: 17874276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment.
    Yang W; Yan K; Goldberg SN; Ahmed M; Lee JC; Wu W; Zhang ZY; Wang S; Chen MH
    World J Gastroenterol; 2016 Mar; 22(10):2993-3005. PubMed ID: 26973395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Survival and prognostic analysis of radiofrequency ablation of hepatocellular carcinoma].
    Yang W; Chen MH; Gao W; Wu W; Huo L; Dai WD; Liu WY; Yan K
    Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):169-73. PubMed ID: 16635345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival.
    Lee MW; Kang D; Lim HK; Cho J; Sinn DH; Kang TW; Song KD; Rhim H; Cha DI; Lu DSK
    Eur Radiol; 2020 Apr; 30(4):2391-2400. PubMed ID: 31900708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical application of ultrasound-guided radiofrequency ablation for primary hepatocellular carcinoma near the liver surface].
    Wu J; Lin S; Wu W; Yan K; Dai Q; Chen M
    Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):933-7. PubMed ID: 26887624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.
    Yang W; Yan K; Wu GX; Wu W; Fu Y; Lee JC; Zhang ZY; Wang S; Chen MH
    World J Gastroenterol; 2015 Feb; 21(5):1554-66. PubMed ID: 25663774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous radiofrequency ablation for early hepatocellular carcinoma: risk factors for survival.
    Kikuchi L; Menezes M; Chagas AL; Tani CM; Alencar RS; Diniz MA; Alves VA; D'Albuquerque LA; Carrilho FJ
    World J Gastroenterol; 2014 Feb; 20(6):1585-93. PubMed ID: 24587635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series.
    Choi D; Lim HK; Rhim H; Kim YS; Lee WJ; Paik SW; Koh KC; Lee JH; Choi MS; Yoo BC
    Eur Radiol; 2007 Mar; 17(3):684-92. PubMed ID: 17093964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors.
    Choi D; Lim HK; Rhim H; Kim YS; Yoo BC; Paik SW; Joh JW; Park CK
    Ann Surg Oncol; 2007 Aug; 14(8):2319-29. PubMed ID: 17522947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection.
    Umeda Y; Matsuda H; Sadamori H; Matsukawa H; Yagi T; Fujiwara T
    World J Surg; 2011 Jan; 35(1):170-7. PubMed ID: 20922387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.
    Wahl DR; Stenmark MH; Tao Y; Pollom EL; Caoili EM; Lawrence TS; Schipper MJ; Feng M
    J Clin Oncol; 2016 Feb; 34(5):452-9. PubMed ID: 26628466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis.
    Lee DH; Lee JM; Lee JY; Kim SH; Han JK; Choi BI
    Cardiovasc Intervent Radiol; 2014 Jun; 37(3):705-15. PubMed ID: 23912493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Favorable Outcomes of Radiofrequency Ablation for Hepatocellular Carcinoma as an Initial Treatment: A Single-center Experience Over a 10-Year Period.
    Tsukamoto M; Yamashita YI; Imai K; Umezaki N; Yamao T; Kaida T; Mima K; Nakagawa S; Hashimoto D; Chikamoto A; Ishiko T; Baba H
    Anticancer Res; 2018 Feb; 38(2):1047-1052. PubMed ID: 29374739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
    Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
    J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.